Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.68 -0.17 (-5.96%)
As of: Oct 2, 2026 · 1:48 PM EDT

Kalaris Therapeutics (KLRS) Long-Term Debt Issuances (2024 - 2025)

Updated

Kalaris Therapeutics' Long-Term Debt Issuances was $7.5 million in FY2025, down 62.4% from $19.97 million in FY2024.

Analysis

Kalaris Therapeutics (KLRS) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $19.97 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Kalaris Therapeutics 68.80 Mn 68.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 7.50 Mn
Dec 31, 2024 9.97 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 4.99 Mn
API Access

Kalaris Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=KLRS&period=max&api_key=YOUR_API_KEY